Merck Serono and EPFL Sign Research Pact in Neuroscience, Oncology Drug Delivery
The Ecole Polytechnique Fédérale de Lausanne and Merck Serono, a division of Merck KGgA, last week announced the signing of a research collaboration in the areas of neuroscience, oncology, and drug delivery.
Under the agreement, three Merck Serono-endowed chairs will be created at EPFL in the three research areas, and Merck Serono will make a total donation of CHF 12.5 million ($10.8 million) to the chairs.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.